文献速递神经肌肉病认知障碍与痴呆

无症状C9orf72六核苷酸重复扩增携带者脑脊液泛素羧基末端水解酶L1同工酶升高

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers.
PubMed 文献 · Ann Neurol · 2024-11-16

横断面观察研究比较48例无症状C9orf72六核苷酸重复扩增携带者与39例年龄匹配非携带者对照的脑脊液生物标志物,发现携带者泛素羧基末端水解酶L1同工酶水平升高(log2倍数变化0.20,FDR校正P=0.034),而神经丝轻链水平无显著差异;该升高在按神经丝水平匹配及多因素校正后仍存在。

要点

  • 无症状C9orf72六核苷酸重复扩增携带者脑脊液泛素羧基末端水解酶L1同工酶水平高于年龄匹配非携带者(log2倍数变化0.20,FDR校正P=0.034)。
  • 两组神经丝轻链水平无显著差异,泛素羧基末端水解酶L1同工酶升高可在神经丝轻链未升高时出现。
  • 按神经丝水平匹配后(P=0.011)及校正年龄、性别、神经丝水平后,泛素羧基末端水解酶L1同工酶升高仍存在。

核心结论

  • 无症状C9orf72六核苷酸重复扩增携带者脑脊液泛素羧基末端水解酶L1同工酶水平升高可出现在神经丝轻链水平未升高的情况下,可能反映快速神经元丢失之前的代偿或致病机制。

研究设计与样本

  • 横断面观察研究纳入48例无症状C9orf72六核苷酸重复扩增携带者、39例无症状非携带者对照、19例散发性肌萎缩侧索硬化(ALS)患者、10例C9orf72 ALS患者、14例散发性额颞叶痴呆(FTD)患者和10例C9orf72 FTD患者。
  • 比较无症状C9orf72六核苷酸重复扩增携带者与年龄匹配非携带者对照的30种预设脑脊液ALS和FTD生物标志物相对丰度,用数据独立采集质谱或电化学发光法测神经丝轻链,并对整个脑脊液蛋白质组进行无偏分析。

主要发现

  • 无症状C9orf72六核苷酸重复扩增携带者泛素羧基末端水解酶L1同工酶水平高于年龄匹配非携带者(log2倍数变化0.20,FDR校正P=0.034),而神经丝轻链水平无显著差异。
  • 按神经丝水平匹配后泛素羧基末端水解酶L1同工酶水平仍升高(P=0.011),校正年龄、性别和神经丝水平后仍升高。
  • 限制分析于按神经丝水平匹配的年轻参与者(<37岁)时也观察到显著差异(P=0.007)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify biochemical changes in individuals at higher risk of developing amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD) via C9orf72 hexanucleotide repeat expansion (HRE) heterozygosity. METHODS: Cross-sectional observational study of 48 asymptomatic C9orf72 HRE carriers, 39 asymptomatic non-carrier controls, 19 people with sporadic ALS, 10 with C9orf72 ALS, 14 with sporadic FTD, and 10 with C9orf72 FTD. Relative abundance of 30 pre-defined cerebrospinal fluid biomarkers of ALS and FTD were compared in asymptomatic C9orf72 HRE carriers and age-matched non-carrier controls. Differential abundance of these proteins was quantified using data independent acquisition mass spectrometry or electro chemiluminescent assay for neurofilament light chain. Unbiased analysis of the entire cerebrospinal fluid proteome was then carried out. RESULTS: Ubiquitin carboxyl-hydrolase isozyme L1 levels were higher in asymptomatic C9orf72 HRE carriers compared with age-matched non-carriers (log2fold change 0.20, FDR-adjusted p-value = 0.034), whereas neurofilament light chain levels did not significantly differ. Ubiquitin carboxyl-hydrolase isozyme L1 levels remained elevated after matching of groups by neurofilament levels (p = 0.011), and after adjusting for age, sex, and neurofilament levels. A significant difference was also observed when restricting analysis to younger participants (<37) matched by neurofilament level (p = 0.007). INTERPRETATION: Elevated cerebrospinal fluid ubiquitin carboxyl-hydrolase isozyme L1 levels in C9orf72 HRE carriers can occur in the absence of increased neurofilament levels, potentially reflecting either compensatory or pathogenic mechanisms preceding rapid neuronal loss. This brings forward the window on changes associated with the C9orf72 HRE carrier state, with potential to inform understanding of penetrance and approaches to prevention. ANN NEUROL 2025;97:449-459.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Dellar ER, Vendrell I, Amein B, et al. Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers. Ann Neurol. 2024. PMID: 39548852. doi:10.1002/ana.27133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。